The Reasons for the Raptiva Recall: The Side Effects of Raptiva
May 9, 2009 by US Drug Recall
Filed under Uncategorized
Up until the beginning of 2009 Raptiva was a medication that was widely used in the United States (as well as in some other countries around the world) to treat psoriasis. Raptiva was administered once a week and acted as an immunosuppressant … it worked to resolve psoriasis by inhibiting while cell migration out of a person’s blood vessels and into that individual’s tissues. Unfortunately, there was a number of very serious side effects associated with Raptiva, these issues resulting in the Raptiva recall. Through this article you are provided an overview of the Raptiva recall.
The Reasons for the Raptiva Recall: The Side Effects of Raptiva
The side effects of Raptiva are varied and significant. It was for this reason that the Raptiva recall was initiated. The most common of the side effects that are underlying the Raptiva recall include:
- Bacterial Sepsis
- Viral Meningitis
- Invasive Fungal Disease
- Progressive Multifocal Leukoencephalopathy
Because an ever increasing number of individuals ended up suffering from one or another of these issues, a Raptiva recall was only a matter of time. However, with that said, there is cause for concern that the Raptiva recall was slow in coming because the manufacturer of the medication has known for an extended period of time that there was a problem with this medication. Indeed, the manufacturer was aware that there were problems associated with Raptiva on a number of different and significant levels.
What You Need to do in Light of the Raptiva Recall
There are a number of steps that you need to take in light of the Raptiva recall if you have used this product. Up front you need to understand that it is important that you take these steps immediately.
1. If you have not already done so, you need to stop using Raptiva today. This is a very serious situation, the Raptiva recall. You simply cannot put off ceasing to use this medication … now!
2. If you feel that you are suffering from any of the symptoms of side effects that have been set forth previously in this article, you need to obtain medical attention immediately.
3. Even if you do not think that you are suffering from one or another of these side effects of using Raptiva, in light of the serious nature of the Raptiva recall, you need to see your doctor for an evaluation.
4. If are suffering from health issues arising out of the use of Raptiva, or if that ends up being the case in the future, you need to consider engaging the services of a qualified, knowledgeable and experienced lawyer to represent your interests and to protect your rights.
If you or someone you love has been injured, please contact the McEwen Law Firm today for a free case evaluation. You may be entitled to serious monetary compensation to cover lost wages, medical expenses and more. Call us toll free today at (800) 732-3070 and talk direct with an attorney that can assist you in recovering your losses. We work on a contingency basis which means you never pay a dime – unless we win your case and recover compensation for you!
Raptiva Recall Lawsuit Due To Brain Infection Side Effects
April 9, 2009 by US Drug Recall
Filed under Uncategorized
Raptiva Recall Lawsuit
McEwen Law Firm is dedicated to investigating the prescription drug Raptiva (efalizumab). Many patients have experienced serious side effects as a result of taking the drug. These side effects have proven life-threatening or fatal which include: PML, brain infections, viral meningitis, sepsis, and invasive fungal disease. The FDA has confirmed these reports including several deaths.
Why Was Raptiva Recalled April 8th, 2009?
On April 8th , 2009, it was announced that Genentech, Inc. had issued a Raptiva Recall in the United States. The drug was pulled as a result of the often fatal brain infection side effects which attacks the central nervous system and known as PML (progressive multifocal leukoencephalopathy).In early 2009, four cases of PML brain infections were linked to Raptiva side effects which resulted in a black box warning by the FDA.
Genetech voluntarily removed Raptiva from the U.S. market because of the serious PML side effects the drug was causing. “Although we believe that many psoriasis patients are benefiting from Raptiva, the balance between benefit and risk in the psoriasis population for which Raptiva was approved has significantly changed,” said Genetech’s senior vice president, Hal Barron, in an April 8th, 2009 statement.
What Are The Raptiva Side Effects?
The FDA reports the serious and potentially life threatening side effects associated with Raptiva which can include:
- Viral Meningitis
- Progressive Multifocal Leukoencephalopathy (PML)
- Invasive Fungal Disease
- Brain Infections
- Psoriasis
If you or someone you love is suffering from life-threatening side effects from the use of Raptiva, please contact a medical professional.
How Do I Seek Recovery?
The McEwen Law Firm is here to help. As a member of the Million Dollar Advocate’s Forum, we have proven ourselves having won over 30, $1 million dollar cases for our personal injury clients. We understand you have rights and we’re to help sure you have them protected. Please use the free case consultation form to the RIGHT (Free Lawyer Consultation) or feel free to call us direct at (800) 732-3070.
We work on a contingency basis which means you never pay a dime to us unless we recover for you. Contact our law firm immediately so we may explain the rights and options you have for you and you family with the Raptiva Recall.
Raptiva Recall Linked To Brain Infections
April 8, 2009 by US Drug Recall
Filed under Uncategorized
The government is warning that taking the psoriasis drug Raptiva could result in serious brain infection and even death.
The Food and Drug Administration cited three confirmed cases, and a possible fourth, of people diagnosed with progressive multifocal leukoencephalopathy (PML) after being treated with Raptiva.
“Three of those patients have died,” the FDA said in a public health advisory. “All four patients were treated with the drug for more than three years…”
Raptiva’s product labeling was revised in October to highlight a boxed warning about the risks of life-threatening infections, including PML.
“At that time, the FDA directed Genentech, the manufacturer, to develop a risk evaluation and mitigation strategy (REMS) to include a medication guide to educate patients about the drug’s risks,” the FDA’s advisory says.
Visit Rhino Recall Lawsuit .com for more information.




